263 related articles for article (PubMed ID: 27692115)
1. Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.
Heinl RE; Dhindsa DS; Mahlof EN; Schultz WM; Ricketts JC; Varghese T; Esmaeeli A; Allard-Ratick MP; Millard AJ; Kelli HM; Sandesara PB; Eapen DJ; Sperling L
Can J Cardiol; 2016 Oct; 32(10 Suppl 2):S349-S357. PubMed ID: 27692115
[TBL] [Abstract][Full Text] [Related]
2. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
Carrington MJ; Zimmet P
BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
Laddu DR; Ozemek C; Hauer TL; Rouleau CR; Campbell TS; Wilton SB; Aggarwal S; Austford L; Arena R
Int J Cardiol; 2020 Feb; 301():156-162. PubMed ID: 31806276
[TBL] [Abstract][Full Text] [Related]
4. [Strategies for cardiovascular prevention in the elderly].
Fattirolli F; Orso F
G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):97S-101S. PubMed ID: 20879492
[No Abstract] [Full Text] [Related]
5. [Nutrition and metabolic syndrome].
Matía Martín P; Lecumberri Pascual E; Calle Pascual AL
Rev Esp Salud Publica; 2007; 81(5):489-505. PubMed ID: 18274353
[TBL] [Abstract][Full Text] [Related]
6. Statins in cardiometabolic disease: what makes pitavastatin different?
Ginsberg H
Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S1. PubMed ID: 23819727
[TBL] [Abstract][Full Text] [Related]
7. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular consequences of metabolic syndrome.
Tune JD; Goodwill AG; Sassoon DJ; Mather KJ
Transl Res; 2017 May; 183():57-70. PubMed ID: 28130064
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Different Interventions for Lifestyle Modifications on the Number of Diagnostic Criteria and Clinical Aspects of Metabolic Syndrome.
Piovesan CH; Gustavo A; Macagnan FE; Saboya PP; Oliveira MDS; Bodanese LC; Ludwig MWB; Closs VE; Feoli AMP
Metab Syndr Relat Disord; 2021 Feb; 19(1):8-17. PubMed ID: 33090083
[No Abstract] [Full Text] [Related]
10. [Prevention and rehabilitation in cardiology].
del Río Ligorit A
Rev Esp Cardiol; 2006; 59 Suppl 1():50-4. PubMed ID: 16540020
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial.
Deedwania P; Murphy SA; Scheen A; Badariene J; Pineda AL; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS; Giugliano RP
JAMA Cardiol; 2021 Feb; 6(2):139-147. PubMed ID: 32785614
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome in systemic lupus erythematosus.
Parker B; Bruce IN
Rheum Dis Clin North Am; 2010 Feb; 36(1):81-97, viii. PubMed ID: 20202592
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes after cardiac rehabilitation in elderly patients with and without diabetes mellitus: The EU-CaRE multicenter cohort study.
Eser P; Marcin T; Prescott E; Prins LF; Kolkman E; Bruins W; van der Velde AE; Peña-Gil C; Iliou MC; Ardissino D; Zeymer U; Meindersma EP; Van'tHof AWJ; de Kluiver EP; Laimer M; Wilhelm M
Cardiovasc Diabetol; 2020 Mar; 19(1):37. PubMed ID: 32192524
[TBL] [Abstract][Full Text] [Related]
16. Cardiac rehabilitation and exercise training programs in metabolic syndrome and diabetes.
Lavie CJ; Milani RV
J Cardiopulm Rehabil; 2005; 25(2):59-66. PubMed ID: 15818190
[No Abstract] [Full Text] [Related]
17. The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomes.
Hoerger TJ; Ahmann AJ
J Manag Care Pharm; 2008 Feb; 14(1 Suppl C):S2-14; quiz 15-6. PubMed ID: 18240890
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of a high-PRotein Mediterranean-style diet and resistance Exercise in cardiac Rehabilitation patients with sarcopenic obesity (PRiMER): Study protocol for a randomised control trial.
McCullough D; Kirwan R; Butler T; Perez de Heredia F; Thijssen D; Lip GYH; Mills J; Davies IG
Clin Nutr ESPEN; 2021 Oct; 45():492-498. PubMed ID: 34620360
[TBL] [Abstract][Full Text] [Related]
19. Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus.
Katsiki N; Anagnostis P; Kotsa K; Goulis DG; Mikhailidis DP
Curr Pharm Des; 2019; 25(18):2051-2059. PubMed ID: 31298151
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
Matsuo Y; Hashizume T; Shioji S; Akasaka T
Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
